ipriflavone has been researched along with Experimental Mammary Neoplasms in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hooshmand, S | 1 |
| Khalil, DA | 1 |
| Murillo, G | 1 |
| Singletary, K | 1 |
| Kamath, SK | 1 |
| Arjmandi, BH | 1 |
1 other study available for ipriflavone and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
The combination of genistin and ipriflavone prevents mammary tumorigenesis and modulates lipid profile.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Isoflavone | 2008 |